Early Blood–Brain Barrier Impairment as a Pathological Hallmark in a Novel Model of Closed-Head Concussive Brain Injury (CBI) in Mice

Stefan J. Blaschke,Nora Rautenberg,Heike Endepols,Aileen Jendro,Jens Konrad,Susan Vlachakis,Dirk Wiedermann,Michael Schroeter,Bernd Hoffmann,Rudolf Merkel,Niklas Marklund,Gereon R. Fink,Maria A. Rueger
DOI: https://doi.org/10.3390/ijms25094837
IF: 5.6
2024-04-30
International Journal of Molecular Sciences
Abstract:Concussion, caused by a rotational acceleration/deceleration injury mild enough to avoid structural brain damage, is insufficiently captured in recent preclinical models, hampering the relation of pathophysiological findings on the cellular level to functional and behavioral deficits. We here describe a novel model of unrestrained, single vs. repetitive concussive brain injury (CBI) in male C56Bl/6j mice. Longitudinal behavioral assessments were conducted for up to seven days afterward, alongside the evaluation of structural cerebral integrity by in vivo magnetic resonance imaging (MRI, 9.4 T), and validated ex vivo by histology. Blood–brain barrier (BBB) integrity was analyzed by means of fluorescent dextran- as well as immunoglobulin G (IgG) extravasation, and neuroinflammatory processes were characterized both in vivo by positron emission tomography (PET) using [18F]DPA-714 and ex vivo using immunohistochemistry. While a single CBI resulted in a defined, subacute neuropsychiatric phenotype, longitudinal cognitive testing revealed a marked decrease in spatial cognition, most pronounced in mice subjected to CBI at high frequency (every 48 h). Functional deficits were correlated to a parallel disruption of the BBB, (R2 = 0.29, p < 0.01), even detectable by a significant increase in hippocampal uptake of [18F]DPA-714, which was not due to activation of microglia, as confirmed immunohistochemically. Featuring a mild but widespread disruption of the BBB without evidence of macroscopic damage, this model induces a characteristic neuro-psychiatric phenotype that correlates to the degree of BBB disruption. Based on these findings, the BBB may function as both a biomarker of CBI severity and as a potential treatment target to improve recovery from concussion.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to study the pathological characteristics of early blood - brain barrier (BBB) injury in closed - head impact brain injury (CBI) by establishing a new mouse model. Specifically, the paper aims to: 1. **Establish a new mouse CBI model**: This model can simulate mild but extensive brain injuries in humans after rotational acceleration / deceleration injuries without causing macroscopic structural damage. The characteristics of this model are unconstrained single or repeated CBI. 2. **Evaluate the impact of CBI on behavioral and cognitive functions**: Through longitudinal behavioral assessment, study the impact of CBI on the spatial cognition, anxiety level and other behavioral manifestations of mice, especially the differences between high - frequency CBI (once every 48 hours) and low - frequency CBI (once a week). 3. **Analyze blood - brain barrier injury after CBI**: Use the methods of fluorescent dextran and immunoglobulin G (IgG) extravasation to evaluate the integrity and degree of damage of the blood - brain barrier after CBI, and explore the relationship between these injuries and neuroinflammation. 4. **Explore the changes of neuroinflammation after CBI**: Detect the neuroinflammatory processes in the mouse brain after CBI through positron emission tomography (PET) and [18F]DPA - 714 markers, and compare and verify with histological results. 5. **Evaluate BBB injury as a biomarker of CBI severity**: The study found that there is a significant correlation between the degree of BBB injury and the cognitive and behavioral deficits caused by CBI (\( R^2 = 0.29 \), \( p < 0.01 \)), which indicates that BBB injury can not only be used as a biomarker of CBI severity, but may also become a therapeutic target for improving CBI recovery. In general, this study provides a new perspective for understanding the pathophysiological process of CBI by establishing an animal model closer to the pathological mechanism of human CBI, and provides potential biomarkers and treatment strategies for the diagnosis and treatment of CBI.